Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/retinal-pharmcotherapeutics/descriptif_3398747
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3398747

Retinal pharmacotherapeutics Developments in Ophtalmology Series, Vol. 55

Langue : Anglais
Couverture de l’ouvrage Retinal pharmacotherapeutics
British Medical Association Medical book awards 2016: "Highly Commended" in the category Internal Medicine
The use of pharmacotherapeutics in the management of retinal diseases is rapidly evolving, and a favorable therapy for the patient. Today anti-VEGF agents are used for a range of indications from inflammation-related choroidal neovascularization to macular edema secondary to retinal vein occlusion or diabetic retinopathy. Beyond VEGF, there is an array of target areas under investigation – not only for vascular pathologies such as age-related macular degeneration and diabetic eye disease, but also for degenerative, infectious and inflammatory retinal conditions.

    This publication discusses many aspects from basic research on the retina, 
    to animal models for retinal drug delivery, retinal diseases that are 
    amenable to pharmacotherapy and also drugs and mechanisms in retinal 
    diseases. Anyone concerned with the management of retinal diseases - the 
    general ophthalmologist and the retina specialist alike – will find this 
    book indispensable reading.

Date de parution :

Ouvrage de 408 p.

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

Prix indicatif 344,85 €

Ajouter au panier

Thème de Retinal pharmacotherapeutics :

Mots-clés :

Ophthalmology